ATTENTION PHARMACISTS: 

URGENT FDA NOTICE: Lamotrigine Orally Disintegrating tablets 200mg Recall

Impax Laboratories, Inc. issued a voluntary nationwide retail level recall on August 19, 2016 for one lot of Lamotrigine Orally Disintegrating Tablet (ODT) 200 mg, NDC 0115-1529-08, Lot # 502240. The affected lot was distributed between June 13, 2016 and August 10, 2016 to wholesale distributors and retail pharmacies nationwide. 

Part D and Medicare Advantage plans only  

Emergency Override for ‘Refill Too Soon’ in North Carolina Due to Tropical Storm  

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceedsthe U.S.  Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.